- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 35/76 - VirusParticules sous-viralesBactériophages
Détention brevets de la classe A61K 35/76
Brevets de cette classe: 3473
Historique des publications depuis 10 ans
|
222
|
248
|
310
|
300
|
310
|
291
|
215
|
231
|
206
|
166
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| iNtRON Biotechnology, Inc. | 178 |
85 |
| The Regents of the University of California | 20924 |
72 |
| The Trustees of the University of Pennsylvania | 4441 |
67 |
| University of Massachusetts | 2337 |
43 |
| CJ Cheiljedang Corporation | 3694 |
38 |
| The University of North Carolina at Chapel Hill | 2125 |
31 |
| University of Florida Research Foundation, Inc. | 4215 |
29 |
| Ottawa Hospital Research Institute | 113 |
26 |
| Institut Pasteur | 779 |
23 |
| Osaka University | 3252 |
23 |
| Massachusetts Institute of Technology | 10313 |
22 |
| The Board of Trustees of the Leland Stanford Junior University | 6722 |
22 |
| Kyoto University | 2941 |
21 |
| Ohio State Innovation Foundation | 2419 |
20 |
| Armata Pharmaceuticals, Inc. | 31 |
20 |
| Takeda Pharmaceutical Company Limited | 2700 |
19 |
| Technophage, Investigacao e Desenvolvimento EM Biotecnologia, SA | 42 |
19 |
| Voyager Therapeutics, Inc. | 292 |
19 |
| Jichi Medical University | 146 |
17 |
| Oncolytics Biotech Inc. | 45 |
17 |
| Autres propriétaires | 2840 |